Evidence map›Paper›PMID 39745873›Full record

ArticleeLife2025

The co-receptor Tetraspanin12 directly captures Norrin to promote ligand-specific β-catenin signaling.

Elise S Bruguera, Jacob P Mahoney, William I Weis

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Development of the blood-brain barrier.Development (Cambridge, England) · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Elise S BrugueraDepartments of Molecular & Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, United States.ORCID https://orcid.org/0000-0003-1983-3013
Jacob P MahoneyDepartments of Molecular & Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, United States.
William I WeisDepartments of Molecular & Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, United States.ORCID https://orcid.org/0000-0002-5583-6150

Funding

Molecular mechanisms of Wnt and mechanical signaling through β-cateninR35GM131747 · NIGMS · STANFORD UNIVERSITY · PI POKUTTA, SABINE · 2019 to 2023
$3.1M
Biochemical reconstitution of Wnt signaling complexesF32GM126642 · NIGMS · STANFORD UNIVERSITY · PI MAHONEY, JACOB P · 2017 to 2020
$186k
Molecular mechanism of Norrin signaling through Frizzled4 and LRP5/6F31EY031947 · NEI · STANFORD UNIVERSITY · PI BRUGUERA, ELISE · 2020 to 2022
$118k
NEI NIH HHS F31 EY031947NIGMS NIH HHS F32 GM126642NIGMS NIH HHS R35 GM131747NIH HHS EY031947NIH HHS GM126642NIH HHS GM131747
6 · The paper itself

Abstract

Wnt/β-catenin signaling directs animal development and tissue renewal in a tightly controlled, cell- and tissue-specific manner. In the mammalian central nervous system, the atypical ligand Norrin controls angiogenesis and maintenance of the blood-brain barrier and blood-retina barrier through the Wnt/β-catenin pathway. Like Wnt, Norrin activates signaling by binding and heterodimerizing the receptors Frizzled (Fzd) and low-density lipoprotein receptor-related protein 5 or 6 (LRP5/6), leading to membrane recruitment of the intracellular transducer Dishevelled (Dvl) and ultimately stabilizing the transcriptional coactivator β-catenin. Unlike Wnt, the cystine knot ligand Norrin only signals through Fzd4 and additionally requires the co-receptor Tetraspanin12 (Tspan12); however, the mechanism underlying Tspan12-mediated signal enhancement is unclear. It has been proposed that Tspan12 integrates into the Norrin-Fzd4 complex to enhance Norrin-Fzd4 affinity or otherwise allosterically modulate Fzd4 signaling. Here, we measure direct, high-affinity binding between purified Norrin and Tspan12 in a lipid environment and use AlphaFold models to interrogate this interaction interface. We find that Tspan12 and Fzd4 can simultaneously bind Norrin and that a pre-formed Tspan12/Fzd4 heterodimer, as well as cells co-expressing Tspan12 and Fzd4, more efficiently capture low concentrations of Norrin than Fzd4 alone. We also show that Tspan12 competes with both heparan sulfate proteoglycans and LRP6 for Norrin binding and that Tspan12 does not impact Fzd4-Dvl affinity in the presence or absence of Norrin. Our findings suggest that Tspan12 does not allosterically enhance Fzd4 binding to Norrin or Dvl, but instead functions to directly capture Norrin upstream of signaling.

Indexed as

beta CateninEye ProteinsNerve Tissue ProteinsTetraspaninsAnimalsFrizzled ReceptorsHumansLigandsProtein BindingSignal TransductionWnt Signaling Pathwaybeta CateninEye ProteinsFrizzled ReceptorsLigandsNDP protein, humanNerve Tissue ProteinsTetraspaninsTSPAN12 protein, humancell signalingco-receptordevelopmental biologyhumanmolecular biophysicsmousenanodiscsspecificitystructural biologyWnt

Identifiers

PMID39745873
PMCPMC11695057

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.